BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help
Search Results
Documents 1-4 out of 4 found
  Current Search:  sensipar: 4     
HTML
100%
NPS Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update
IRB Approval Process Underway for Two Registration Studies Conference Call Today at 8:00 AM ET BEDMINSTER, N.J., Nov.

5, 2008--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc.

(NASDAQ: NPSP), a specialty pharmaceutical company focused on...

Pharma Live:  Nov 5 2008 5:54PM
Matching: sensipar 		Find similar documents
HTML
100%
FDA Pulls Amgen Brochure for Misleading Language
Amgen offered a statement to Pharm Exec explaining that the letter received was not a warning letter, but an untitled letter addressing alleged promotion violations that are less serious than those addressed in warning letters.

Amgen is...

Pharmaceutical Executive:  Nov 5 2008 6:15AM
Matching: sensipar 		Find similar documents
HTML
100%
FDA Sends Letter to Amgen Over Sensipar DTC Brochure
ROCKVILLE, Md., Oct.

29, 2008-The Food and Drug Administration today posted on its website a letter sent to Amgen, Inc.

over a direct-to-consumer patient brochure for Sensipar tablets.

The letter is below.

*********************...

Pharma Live:  Oct 30 2008 3:48PM
Matching: sensipar 		Find similar documents
HTML
100%
BRIEF-US FDA: Amgen brochure for Sensipar drug misleads
- Oct 29 (Reuters) - The U.S.

Food and Drug Administration said in a letter to Amgen Inc released on Wednesday: * An Amgen patient brochure for its kidney disease drug Sensipar misleads patients * The direct-to-consumer brochure 'is...

Sharewatch:  Oct 29 2008 8:59PM
Matching: sensipar 		Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.